(Circulation. 1995;92:467-471.)
© 1995 American Heart Association, Inc.
Articles |
Creation of a Controlled Venoarterial Shunt
A Surgical Intervention for Right-Side Circulatory Failure
Presented in part at the 67th Scientific Sessions of the American Heart Association, Dallas, Tex, November 14-17, 1994, and published in abstract form (Circulation. 1994;90[pt 2]:I-161).
From the Division of Cardiothoracic Surgery, Department of Surgery (J.P.S., A.Y., O.J.Y., R.S., D.J.G., H.M.S., M.C.O.) and the Department of Medicine, Division of Circulatory Physiology (H.R.L.), Columbia University College of Physicians and Surgeons, New York, NY.
Correspondence to James P. Slater, MD, Department of Surgery, Columbia-Presbyterian Medical Center, 622 West 168th St, Box 188, New York, NY 10032.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Background Right-side circulatory failure (RSCF), a common complication of heart transplant and left ventricular assist device recipients, results in decreased cardiac output because of diminished flow across the pulmonary circuit. We hypothesized that creation of a controlled venoarterial shunt would result in decompression of the right ventricle and improved systemic cardiac output at tolerable oxygen saturations.
Methods and Results A venoarterial shunt was created in a large-animal model (calf, n=6). RSCF was induced by banding the pulmonary artery. Hemodynamic measures and blood gas determinations were obtained during nonshunted and shunted states. Pulmonary artery banding increased mean right ventricular systolic pressure from 44.9±2.1 mm Hg (mean±SEM) to 85.9±6.9 mm Hg (P<.05, paired t test) and decreased mean aortic flow from 7.8±1.0 to 4.2±1.1 L/min (P<.05). Flow through a venoarterial shunt at approximately 40% of cardiac output resulted in a decrease in right ventricular end-systolic pressure from 85.9±6.9 to 72.1±5.6 mm Hg (P<.01, ANOVA), a decrease in mean pulmonary artery pressure from 42.9±5.0 to 37.2±3.8 mm Hg (P<.01), and an increase in aortic flow from 4.2±.05 to 5.1 L/min (P<.01). Left ventricular stroke work decreased from 2.22±0.28 to 1.55±0.88 (P<.05). Carotid artery oxygen saturation did not change significantly (99.9±.02 to 97.6±1.7) during shunting.
Conclusions A controlled venoarterial shunt improved hemodynamics and cardiac output in a large animal model with RSCF. This strategy may be useful in the management of transplant and left ventricular assist device recipients with perioperative RSCF.
Key Words: shunts • transplantation
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Right-side circulatory failure (RSCF) is a multifactorial entity in which the final common pathway is diminished blood flow across the pulmonary circuit, resulting in a lower systemic cardiac output. RCSF is the primary cause of death in 10% to 20% of early mortality (<30 days) after cardiac transplantation,1 2 usually owing to increased pulmonary vascular resistance in the recipient or donor organ dysfunction.3 Perioperative RSCF is also a complication in 20% to 40% of the increasing number of patients receiving left ventricular assist devices and is the leading cause of perioperative mortality.4 5 Causes in this population include altered ventricular interdependence and acute increased pulmonary vascular resistance in coagulopathic patients after prolonged cardiopulmonary bypass.5 6 7
Pharmocological therapy for RSCF includes pulmonary vasodialators and inotropic support for the right ventricle (RV). RV assist devices can provide mechanical assistance for RSCF refractory to drug therapy. RV assist devices are capable of maintaining adequate cardiac output in most patients but may fail when pulmonary vascular resistance is extremely elevated and increased flow to the pulmonary artery results in RV distension and a leftward shift of the ventricular septum, which limits left ventricular filling.8
In an effort to identify a new and complementary approach to treating RSCF, we studied venoarterial shunting in a large animal model with induced RSCF. We hypothesized that this shunt would decompress the RV and improve systemic hemodynamic stability, with tolerable levels of arterial desturation.
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
All animals received humane care in compliance with the Principles of Laboratory Animal Care formulated by the Institute of Laboratory Animal Resources and the Guide for the Care and Use of Laboratory Animals prepared by the National Institutes of Health (NIH Publication 86-23, revised 1985).
Six Holstein calves weighing between 80 and 100 kg were preanesthetized with midazolam (0.1 mg/kg IM) and ketamine (10 mg/kg IM). Anesthesia was induced with thiamylal (7 to 10 mg/kg IV), and after intubation, anesthesia was maintained with inhaled isoflurane (1.5% to 1.75% in 2 to 3 L O2).
In the left lateral decubitus position, a left thoracotomy was performed with excision of the fifth rib. The inferior pulmonary ligament was divided, and the lung was retracted dorsally. The pericardium was incised longitudinally. The aorta was dissected free to the ductus arteriosis, dividing the azygous vein. The ductus was clamped to eliminate the possibility of a naturally occurring left-to-right shunt. The pulmonary artery was isolated proximal to its bifurcation.
A shunt circuit was created from the right atrium (32-mm cannula, Bard
Co) to the right femoral artery (18-mm Bard femoral cannula) (Fig
1
). The right atrial venous line was connected to a
centrifugal pump (Biomedicus, Inc). Flow was returned to the right
femoral artery. An in-line OxySAT 0200 (Baxter Health Care Corp)
oxygen saturation meter was placed in the venous return line.
|
Instrumentation
Ultrasonic flow probes (Transonic Systems
Inc) were placed
around the pulmonary artery, descending aorta, and left carotid
and left femoral arteries. Micromanometer pressure
transducers (Millar Instruments Inc) were placed in the RV,
pulmonary artery, and left ventricle after calibration with a
water column. A Swan-Ganz catheter in the pulmonary artery and
catheters in the superior and inferior venae cavae and
carotid and femoral arteries allowed measurement of blood pH and oxygen
saturation.
An umbilical tape placed around the pulmonary artery was fastened to a ratcheted snare and used to band the pulmonary artery in an incremental fashion.
Dose-Response Curve
To establish an upper limit of tolerable
shunt flow, mixed
venous oxygen saturation was measured while increasing shunt flow from
0 to 5000 mL/min by increments of 500 mL/min. After a 4-minute
stabilization period at each level, pulmonary artery samples
were obtained. The procedure was repeated for each limb of the shunt
circuit.
The optimal shunt flow rate was defined as the maximal flow with a venous oxygen saturation of >60%. This produced an arterial oxygen saturation of >90%. Once the optimal shunt flow rate was determined, it was used consistently for that animal throughout the remainder of the experiment.
Experimental Protocol
The experimental protocol required
right-side circulatory
failure to be established, after which right-to-left shunting
was initiated to improve hemodynamic stability. RSCF
was defined by a >50% increase in RV and pulmonary artery
pressures with a simultaneous >50% decrease in aortic
flow (cardiac output). After baseline data were obtained, the
pulmonary artery was banded to produce RSCF. The calf was
allowed to stabilize for 4 minutes before all measures were repeated.
Venoarterial shunt flow was then instituted at the
optimal shunt flow rate through the shunt circuit. Four minutes later,
measurements were repeated. Shunt flow was stopped, and the
pulmonary artery band was removed. The animal was allowed to
stabilize before the pulmonary artery band was reapplied and
the above protocol was repeated.
Data were digitized in real-time at a speed of 200 Hz by an analog-to-digital converter (MacLab MkIII, MacLab/8, ADInstruments, Pty Ltd), filtered with a 50-Hz low-pass filter and recorded with a Macintosh computer (Macintosh IIcx, Apple Computers Inc). Blood gas determinations were performed with a Nova Stat 3 Profile (Nova Biomedical Inc).
Hemodynamic variables were measured for each experimental condition, including RV end-diastolic and peak systolic pressures, pulmonary artery pressure (PAP), left ventricular end-diastolic pressure (LVEDP), pulmonary artery flow (PAF), descending aortic flow (AoF), and carotid artery flow (CF). During left atrial–to–femoral artery shunting, aortic flow was calculated as measured flow plus shunted flow, as shunted blood enters the arterial circulation distal to the flow probe. Oxygen saturation was obtained simultaneously from the carotid, femoral, and pulmonary arteries and the inferior and superior venae cavae. Last, pH determinations were performed at the carotid artery and femoral vein.
Right and left ventricular stroke work (SW) calculations were performed for all experimental states (SW=stroke volumexmean ventricular pressure). RV stroke volume was calculated by dividing PAF by heart rate. Left ventricular stroke volume during shunt flow was calculated as stroke volume=(measured AoF+measured CF+shunt flow)/heart rate.
An unpaired Student's t test was used to compare mean values during baseline and right circulatory failure conditions. A paired ANOVA with the Bonferroni multiple-comparisons test was used to compare the shunted state with the RSCF condition.
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Dose-Response Curve
Calves tolerated shunt flows approaching 50% of cardiac output. Representative data from one animal are presented in Fig 2
. This animal had a baseline
cardiac output of 8.0 L/min. Shunt flow is represented as a
percentage of cardiac output versus mixed venous oxygen saturation.
|
Model Efficacy
A representative example of the effects of
pulmonary artery banding and venoarterial
shunting is presented in Fig 3.
Pulmonary artery banding caused an increase in right-side
pressures and a decrease in left-side pressures. Flow through the
pulmonary artery, aorta, and carotid artery were also
decreased. Shunting resulted in decreased right-side pressures and
improved flow through both pulmonary and systemic
circulations.
|
Mean hemodynamic effects of banding the
pulmonary artery to create RSCF are presented in the
Table. The RV end-diastolic and peak
systolic pressures were increased markedly (P<.05),
and LVEDP decreased (P<.05) after placement of the
pulmonary artery band. PAF, AoF, and CF decreased
(P<.05).
|
Arterial oxygen saturation was unchanged at all sites measured, but venous saturation decreased (P<.05). Neither arterial pH from the carotid artery nor venous pH from the femoral artery changed significantly.
Effects of Shunt
The mean effects of a venoarterial shunt on
pulmonary and systemic hemodynamic
parameters, oxygen saturation, and blood pH are
presented in the Table
and Fig 4 through
7. RV pressures
and PAP
decreased with shunting (P<.01) (Fig 4). LVEDP also
decreased during shunting (P<.05) (Fig 4). PAP and
AoF
increased during shunt flow (P=.07 and P<.01,
respectively) (Fig 5). CF did not change significantly during
shunt
flow (Fig 5). Left ventricular SW decreased during shunt
flow (P<.05), whereas RV SW was unchanged (Fig 6).
|
|
|
|
Effects of shunting on oxygen saturation are illustrated in Fig
7.
Carotid artery and superior vena cava oxygen saturation were not
affected by shunting. Femoral artery and inferior vena cava
oxygen saturation markedly decreased (P<.01). Mixed venous
saturation trended lower during shunting; this was not statistically
significant. Carotid artery pH decreased during shunting
(P<.01), as did femoral vein pH (P<.01)
(Table).
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
In 1964, Austen et al9 described the use of a venoarterial shunt as treatment for pulmonary hypertension in an animal model.9 Experiments were based on the observation that patients with primary pulmonary hypertension often died suddenly from right-side heart failure during physical or emotional stress, but patients with Eisenmenger's syndrome (pulmonary vascular disease and intercardiac shunt) rarely died from sudden death. In an acute canine preparation, a nonoxygenated right-to-left shunt was well tolerated in in the presence of increased pulmonary vascular resistance. In a long-term preparation, animals with pulmonary hypertension and an atrial septal defect were able to tolerate strenuous exercise, but animals with pulmonary hypertension and no atrial septal defect died suddenly after the same level of exercise. After the report of Austen et al, there were case reports and one small series in which right-to-left shunts were used clinically to treat patients with end-stage primary pulmonary hypertension.10 11 12 13 14 In the more recent reports, this strategy has been used as a temporizing measure before lung transplantation. Within this small group of patients, there have been some striking successes.
In the present study, in healthy animals, shunt flow rates approaching 50% of cardiac output resulted in a mixed venous oxygen saturation of 60%. This suggests that an animal without pulmonary disease is capable of maintaining adequate oxygenation when only half of the cardiac output is flowing through the pulmonary circulation.
We found that pulmonary artery banding in calves reproducibly increased RV and mean PAP, whereas LVEDP, PAF, AoF, and CF decreased. The effect of decreased systemic flow was detectable as a drop in the mixed venous oxygen saturation. This constellation of changes, consistent with RSCF, was useful for testing hemodynamic effects of a venoarterial shunt.
Instituting flow across a venoarterial shunt increased effective cardiac output. In addition, RV pressure and PAP were decreased as a result of diverting up to 50% of venous return away from the overloaded RV. Surprisingly, we observed a near–statistically significant (P=.07) increase in PAF despite the fixed obstruction and large shunt. This increase may result from increased RV perfusion pressure secondary to decreased RV pressures. A greater perfusion pressure will translate to improved RV performance.8 Similarly, we observed a decrease in LVEDP. Shunting blood directly into the distal aorta increases aortic root pressure, resulting in improved coronary perfusion pressure, and may improve left and right ventricular performance. The decrease in LVEDP may further decrease RV afterload, which may also contribute to increased PAF. A reduced LVEDP has the theoretical benefit of decreasing the work of the left ventricle by lowering filling pressures. This was observed as a decrease in left ventricular SW during shunted flow with a simultaneous increase in AoF. An increase in effective cardiac output while lowering LV SW represents a significant hemodynamic advantage to the left ventricle.
The physiological cost of a right-to-left shunt is decreased systemic blood oxygen saturation. Oxygen saturation was most affected at the level where the admixture of deoxygenated and oxygenated blood occurred. Venous desaturation paralleled arterial desaturation. Mixed venous oxygen saturation, an approximate index of mean tissue oxygen levels,15 was not significantly decreased during shunt flow. Femoral artery and inferior vena cava oxygen saturations were markedly decreased with shunting, but blood flowing to the head remained fully oxygenated. The risks of shunting blood peripherally, in the manner described, are ischemic damage to the lower extremities and local lactic acid production, resulting in a systemic acidosis. Arterial blood gas determinations at the carotid artery and femoral vein revealed statistically significant but not clinically significant changes in pH (>7.3 and >7.2, respectively). This suggests no profound systemic or local acidosis as a result of the venoarterial shunt.
These initial studies indicate that a venoarterial shunt may be useful in the treatment of perioperative RSCF. The major limitation of the present study is the relatively short duration of observed shunt flow. The effects of shunting on arterial oxygen saturation and blood pH may not fully manifest during the time course studied. This study demonstrates that a controlled venoarterial shunt has a beneficial effect on the hemodynamic profile of a large animal with induced RSCF. These effects can be obtained at flow rates that do not result in significant oxygen desaturation. These results may lead to an improved short-term treatment strategy for transplant and left ventricular assist device recipients who develop RSCF in the perioperative period.
|
Acknowledgments |
|---|
This work was supported in part by Irving Assistant Professorship (Dr Oz) and a clinical research award (Dr Slater), Columbia University, New York, NY. Dr Oz is an Irving Research Scholar. We thank Alan Weinberg, PhD, for advice and statistical analysis. We also thank the members of the Institute of Comparative Medicine at Columbia University and the Perfusion Team at Columbia-Presbyterian Hospital, without whom completion of the study would not have been possible.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Hauptman PJ, Aranki S, Mudge GH Jr, Couper GS, Loh E. Early cardiac allograft failure after orthotopic heart transplantation. Am Heart J. 1994;127:179-186. [Medline] [Order article via Infotrieve]
2. Terasaki PI. Clinical Transplants. Los Angeles, Calif: UCLA Tissue Typing Laboratory; 1990;21-27.
3. Emery RW, Eales F, Joyce LD, Von Rueden TJ, King RM, Jorgensen CR, Pritzker MR, Johnson KE, Lake KD, Arom KV. Mechanical circulatory assistance after heart transplantation. Ann Thorac Surg. 1991;51:43-47. [Abstract]
4. Kawai A, Kormos RL, Mandarino WA, Morita S, Deneault LG, Gasior TA, Armitage JM, Griffith BP. Differential regional function of the right ventricle during the use of a left ventricular assist device. ASAIO. 1992;38:M676-M678. [Medline] [Order article via Infotrieve]
5. Farrar DJ, Compton PG, Hershon JJ, Fonger JD, Hill JD. Right heart interaction with the mechanically assisted left heart. World J Surg. 1985;9:89-102. [Medline] [Order article via Infotrieve]
6. Mandarino WA, Morita S, Kormos RL, Kawai A, Deneault LG, Gasior TA, Losken B, Griffith BP. Quantitation of right ventricular shape changes after left ventricular assist device implantation. ASAIO J. 1992;38:M228-M231. [Medline] [Order article via Infotrieve]
7.
Farrar JD, Compton PG, Dajee H, Fonger JD, Hill JD.
Right heart function during left heart assist and the effects of
volume loading in a canine preparation.
Circulation. 1984;70:708-716.
8.
Kelly DT, Spotnitz HM, Beiser GD, Pierce JE, Epstein
SE. Effects of chronic right ventricular volume and
pressure loading on left ventricular
performance. Circulation. 1971;44:403-412.
9. Austen WG, Morrow AG, and Berry WB. Experimental studies of the surgical treatment of primary pulmonary hypertension. J Thorac Cardiovasc Surg. 1964;48:448-455.
10. Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol. 1983;51:1560-1561. [Medline] [Order article via Infotrieve]
11. Collins TJ, Moore JW, Kirby WC. Atrial septostomy for pulmonary hypertension. Am Heart J. 1988;116:873-874. [Medline] [Order article via Infotrieve]
12. Hausknecht MJ, Sims RE, Nihill MR, and Cashion R. Successful palliation of primary pulmonary hypertension by atrial septostomy. Am J Cardiol. 1990;65:1045-1046. [Medline] [Order article via Infotrieve]
13. Nihill MR, O'Laughlin MP, Mullins CE. Effects of atrial septostomy in patients with terminal cor pulmonale die to pulmonary vascular disease. Cathet Cerebrovasc Diagn. 1991;24:166-172.
14. Rothman A, Beltran D, Kriett JM, Smith C, Wolf P, Jamieson SW. Graded balloon dilation atrial septostomy as a bridge to lung transplantation in pulmonary hypertension. Am Heart J. 1993;125:1763-1766. [Medline] [Order article via Infotrieve]
15. Kirklin JW, Barret-Boyes BG, eds. Cardiac Surgery, 2nd ed. New York, NY: Churchill-Livingston; 1990
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||